• Socioeconomic And Environmental Determinants In Breast Cancer Incidence And Mortality- Scientiometric Review, 2006 - 2016

    Oct 1, 2017, 00:00

  • Drug Utilization Study Of Antibacterial In The Medical Intensive Care Unit (Micu) Of A Chitwan Medical College Teaching Hospital(Cmcth), Bharatpur, Chitwan, Nepal

    Oct 1, 2017, 00:00

  • Patient Preferences Regarding Treatment Options for Relapsed Refractory Multiple Myeloma (RRMM)

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of The Paliperidone Palmitate 3-Month Formulation Versus 1-Month Formulation From A Healthcare Payer Perspective

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Peritoneal Dialysis Provision for the Treatment of Chronic Kidney Disease from Public Health Perspective in Chile

    Oct 1, 2017, 00:00

  • The Role Of General Practitioners In Diagnostic Delay In Case Of Cutaneous Malignant Melanoma Patients

    Oct 1, 2017, 00:00

  • The Economic Burden Of Acute Bacterial Rhinosinusitis And Acute Otitis Media In Turkey- An Epidemiology Based Cost Of Illness Study With Respect To Clinical Practice And Available Guidelines

    Oct 1, 2017, 00:00

  • Electronic Capture of Clinical Outcome Assessment Data- Why is it Not Used More in Clinical Studies?

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life after Oncological Resection and Reconstruction of the Chest Wall

    Oct 1, 2017, 00:00

  • The First Five Months Of National Prescription Monitoring In Finland

    Oct 1, 2017, 00:00

  • The Design of Economic Evaluation and Budget Impact Analysis Of Biosimilars- A Qualitative Study

    Oct 1, 2017, 00:00

  • Trends In Fda Drug Promotion Enforcement Letters Over A Ten-Year Period

    Oct 1, 2017, 00:00

  • Treatment Choices Based On Multiplatform Profiling Platform, Unlike Those With Sequencing Alone, Do Not Cause A Cost Explosion In Refractory Cancer Patients

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Comparing Blinatumomab In The Treatment Of Adults With Philadelphia Chromosome-Negative Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (All) With Flag-Ida And Hyper CVAD

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Sequential Vaccination Of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) And 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) On Adult Population In South Korea

    Oct 1, 2017, 00:00

  • The Economic Impact of Caregiver For Patients With Atrial Fibrillation- An Italian Survey

    Oct 1, 2017, 00:00

  • Dose Appropriateness of Antibiotics- Deciphering Infections in Renal Imprirement

    Oct 1, 2017, 00:00

  • The Economic Burden of Varicella in Peru

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Switching To Insulin Degludec (IDEG) In Real-World Clinical Practice In Italy

    Oct 1, 2017, 00:00

  • Relationship Between The Price Differences In Orphan Drugs With More Than One Benefit Assessment In Amnog And The Potential Influencing Factors

    Oct 1, 2017, 00:00

  • Quick and Comprehensive Assessment of Narrow Band Imaging (NBI) Using in Digestive Tract Examination

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Tigecycline In Comparision With Imipenem/Cilastatin Or Piperacillin/Tazobactam In The Treatment Of Complicated Intra-Abdominal Infections- A Perspective Of Iranian Health Systems

    Oct 1, 2017, 00:00

  • Prognostic and Treatment Effect Modifying Baseline Factors for Visual Functioning Response in Non-Infectious Uveitis of the Posterior Segment Treated with Intravitreal Sirolimus

    Oct 1, 2017, 00:00

  • Leadership In Nursing

    Oct 1, 2017, 00:00

  • Cost Minimization Analysis of The Selective Aromatase Inhibitors; Anastrozole, Versus Letrozole and Exemestane for The Management of Breast Cancer From Patient Perspective in Egypt

    Oct 1, 2017, 00:00

  • The Effect of Smoking Cessation Interventions in Patients with Copd- A Systematic Review

    Oct 1, 2017, 00:00

  • Bevacizumab for Breast Cancer- Scientific Evidence Versus Real World Data (RWD) in Brazil

    Oct 1, 2017, 00:00

  • Pharmacology for Peripheral Arterial Disease in the Netherlands; Patient Journey and Platelet Aggregation Inhibitor Prescription

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis of The Use of Enstilar® Compared To Dovobet® Gel In The Treatment of Psoriasis In Italy

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Empagliflozin For The Treatment of Patients With Type 2 Diabetes Mellitus At Increased Cardiovascular Risk In Greece

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of Physicians' Guideline Adherence for Osteoporosis In Germany

    Oct 1, 2017, 00:00

  • Using Outcome Data to Inform Healthcare Professional – Patient Discussion- A Database of Treatment Effects

    Oct 1, 2017, 00:00

  • Healthcare Resource Use (HRU) in Hospitalized Patients with a Diagnosis of Spinal Muscular Atrophy Type 1 (SMA1)- Retrospective Analysis of The Kids’ Inpatient Database (KID)

    Oct 1, 2017, 00:00

  • Acute Lymphoblastic Leukaemia’s Burden Of Disease In Portugal

    Oct 1, 2017, 00:00

  • Comparison Of Utility Cost In Three Commercially Available Precision Medicine Approaches In Oncology

    Oct 1, 2017, 00:00

  • Radar – An Important Tool for Horizon Scanning Dissemination in Brazil

    Oct 1, 2017, 00:00

  • Patient Outcomes In Wales- The Proms, Prems Effectiveness Programme (PPEP)

    Oct 1, 2017, 00:00

  • Incidence Of Surgery For Inflammatory Bowel Disease Within 12 Months Of Initiation Of Vedolizumab Or Infliximab

    Oct 1, 2017, 00:00

  • Multiple Myeloma- Epidemiology and Burden of Disease Analysis in Latin America

    Oct 1, 2017, 00:00

  • Societal Preferences For Funding Orphan Drugs In The UK- An Application Of Value Based Pricing Using Discrete Choice Experiment Methods

    Oct 1, 2017, 00:00

  • Evaluating Community Pharmacists’ Response To Adverse Drug Events Among Women With Pcos- A Simulated-Client Study

    Oct 1, 2017, 00:00

  • Differences in Distributional Properties and Responsiveness Between A Generic (EQ-5d) and Disease-Specific (ASUI) Utility Instrument in Patients with Severe Eosinophilic Asthma

    Oct 1, 2017, 00:00

  • Challenges and Future Perspectives on The Reimbursement of Advanced Therapy Medicinal Products

    Oct 1, 2017, 00:00

  • real-World Data (RWD) On The Attainment Of Composite Quality Measures (Cqm) In A Brazilian Population With Self-Reported Type-2 Diabetes Mellitus (T2DM)

    Oct 1, 2017, 00:00

  • Boosting Home Dialysis Uptake By Setting Fixed Modality Ceilings- Is It An Evidence-Based Policy Approach?

    Oct 1, 2017, 00:00

  • Effect of Anti-Diabetic Drugs On Risk of Fracture In Type 2 Diabetes Mellitus Patients- A Network Meta-Analytic Synthesis of Randomized Controlled Trials of Thiazolidinediones

    Oct 1, 2017, 00:00

  • Health Insurance Cost Of Migraine In Hungary- A Cost Of Illness Study

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Ustekinumab in Moderate to Severely Active Crohn’s Disease in Sweden

    Oct 1, 2017, 00:00

  • A Cost Minimization Analysis of Azelastine/Fluticasone Combination Nasal Spray Versus Azelastine And Fluticasone Nasal Sprays Monotherapy In Moderate To Severe Allergic Rhinitis- An Experience From Islamic Republic of Iran

    Oct 1, 2017, 00:00

  • The Cost Effectiveness of Abobotulinumtoxin A For Hemiparesis In Adults With Upper Limb Spasticity After Stroke or Traumatic Brain Injury In The United Kingdom – A Bayesian Analysis

    Oct 1, 2017, 00:00

  • The Prevalence of Patients At Very High Risk For Cardiovascular Events In The United Kingdom

    Oct 1, 2017, 00:00

  • A Pilot Study About The Appropriateness Of The Breast Cancer Care Pathway In A Local Health Authority ASL CN2 (Piedmont, ALBA BRA-Italy) based on E.Pic.A. (Economic Appropriateness Of An Integrated Care Pathway) Protocol

    Oct 1, 2017, 00:00

  • Quantitative Assessment of Ophthalmologist Prescribing Patterns for Severe Vernal Keratoconjunctivitis (VKC) To Inform Payer Decision Making In The Eu

    Oct 1, 2017, 00:00

  • Probabilistic Cost-Utility Analysis of Pergoveris in Women Patients Undergoing IVF

    Oct 1, 2017, 00:00

  • Development And Utility Valuation Of Health States For Haemophilia And Related Complications In Europe And In The USA

    Oct 1, 2017, 00:00

  • Health Economic Cost Study For Senior Citizens In Ecuador

    Oct 1, 2017, 00:00

  • The Early Bird Catches The Worm- Measuring The Potential Value Of Mesenchymal Stem Cells Therapy For Septic Shock Using The Early Health Economic Evaluation

    Oct 1, 2017, 00:00

  • Instructions for Authors

    Oct 1, 2017, 00:00

  • Identifying Inpatients To Outpatient Parenteral Antimicrobial Therapy- A Point Prevalence Study

    Oct 1, 2017, 00:00

  • Public Funding Of Cancer Treatment- Changes To The Process And Success Rate Over Time In Australia

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of First-Line Ceritinib in The Treatment of Alk+ Metastatic Non-Small Cell Lung Cancer (NSCLC) in The United States

    Oct 1, 2017, 00:00

  • Healthcare Resource Utilization in Patients with Moderate to Severe Ulcerative Colitis- A Brazilian Real World Study

    Oct 1, 2017, 00:00

  • Comparing Efficacy of Guselkumab Versus Ustekinumab in Moderate to Severe Psoriasis Patients - An Adjusted Comparison Based on Voyage 12 and Navigate Trials

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Eicosapentaenoic Acid (EPA) On Primary Prevention of Cardiovascular Disease

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis of The Use Of Daclatasvir + Asunaprevir in The Treatment of Patients with Chronic Hepatitis C in Peru

    Oct 1, 2017, 00:00

  • Fatores Associados Aos Gastos com Imagenologia No Sistema Unico De Saude Brasileiro

    Oct 1, 2017, 00:00

  • Evaluating Cost of Regimens in Hepatitis C Treatment from Healthcare Payer Vietnam’s Perspective

    Oct 1, 2017, 00:00

  • A Preliminary Cost Analysis of Schizophrenic Patients Stabilized on 1-Monthly Long Acting Paliperidone Palmitate (PP1M) Injection Switching To Paliperidone Palmitate 3-Monthly Formulation (PP3M) In The Public Sector of Hong Kong

    Oct 1, 2017, 00:00

  • Health Care Resource Utilization Among Patients With Moderate-To-Severe Plaque Psoriasis In Brazil

    Oct 1, 2017, 00:00

  • Utility Meta-Regression; Frequentist Vs Bayesian Approaches in Multiple Myeloma

    Oct 1, 2017, 00:00

  • The Impact Of Long Acting Injectable Antipsychotics On The Health And Economic Outcomes Of Schizophrenia Patients In Brazil

    Oct 1, 2017, 00:00

  • HTA Reports In Gene And Cell Therapy Products- A Scoping Review

    Oct 1, 2017, 00:00

  • Yellow Fever’s Next Move- The Rising Fear

    Oct 1, 2017, 00:00

  • Are Generic Health State Utility Instruments Sufficiently Sensitive To Capture Changes In Health-Related Quality of Life In Patients With Visual Disorders?

    Oct 1, 2017, 00:00

  • Development of a New Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis- Nash-Check

    Oct 1, 2017, 00:00

  • Length of Hospitalisation After Attune® Knee Joint Arthroplasty (TKA) - Results of A German Retrospective Database Analysis

    Oct 1, 2017, 00:00

  • The Success Of EU Omp Legislation- An Empirical Analysis

    Oct 1, 2017, 00:00

  • Medication Use During Pregnancy in the Netherlands- A Population-Based Study

    Oct 1, 2017, 00:00

  • Validação Do Método Simple Exponential Smoothing with Additive Para Realização De Previsões De Gasto Com Importação De Produtos Farmacêuticos

    Oct 1, 2017, 00:00

  • Modelling The Effectiveness of Ibrutinib Versus Physician’s Choice (PC) In Relapsed or Refractory (RR) Waldenström’s Macroglobulinemia (WM) Within England

    Oct 1, 2017, 00:00

  • Survival Outcomes Predicted By A Discrete Event Simulation Model For Renal Cell Carcinoma For Use In A Cost Effectiveness Analysis- A Comparison With A Traditional Partitioned Survival Model

    Oct 1, 2017, 00:00

  • Caracterización Clínica Y Económica De Hospitalización Por Varicela En Niños En La Región Metropolitana Y Región De Valparaíso, Chile

    Oct 1, 2017, 00:00

  • Evaluación De Pertinencia Científica Y Análisis De Costo-Efectividad En Las Intervenciones De Salud

    Oct 1, 2017, 00:00

  • Contrasting Improving Rates of Cancer Survival In The Context of Life Years Lost Compared To The General Population

    Oct 1, 2017, 00:00

  • Persistence in Hypertension Therapy in Patients with and Without Depression in Germany

    Oct 1, 2017, 00:00

  • Patients’ Experiences Living With Chronic Hepatitis B Infection- A Multinational Qualitative Study

    Oct 1, 2017, 00:00

  • Will 2017 Updates To The Highly Specialised Technologies Programme Benefit or Harm Vulnerable Patients?

    Oct 1, 2017, 00:00

  • Cost Illness Of Rsv Infection In Colombia

    Oct 1, 2017, 00:00

  • Estimating the Comparative Accuracy of Diagnostic Tests- AN Example using Typhoid Fever

    Oct 1, 2017, 00:00

  • Cost Saving Due To Self-Care Behavior Of Cardiovascular Patients

    Oct 1, 2017, 00:00

  • Cost Impact of Protocol Compliance for Cancer Treatment Plans in The Private Healthcare Environment

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Supra-Ciliary Microstent Device Utilization In Primary open Angle Glaucoma Patients In A Spanish Hospital Outpatient Setting

    Oct 1, 2017, 00:00

  • Mapping From The Womac To The EQ-5D-5L Questionnaire- Comparison Of Different Methodologies

    Oct 1, 2017, 00:00

  • Comparison of Health Technology Assessments in Rheumatology from 2012 To 2016

    Oct 1, 2017, 00:00

  • Evaluation Of Measles Vaccination Coverage In Austria

    Oct 1, 2017, 00:00

  • Efficacy Of Antioxidant Supplements On Prevention And Amelioration Of Diabetes-Induced Nephropathy- A Systematic Review And Meta-Analysis Of Randomized Controlled Trials

    Oct 1, 2017, 00:00

  • Assessing the Longer-Term Efficacy of Biologic Therapies and Apremilast for Patients with Moderate-To-Severe Psoriasis- A Systematic Review and Network Meta-Analysis

    Oct 1, 2017, 00:00

  • The Economic And Humanistic Burden of Patients on Treatment for Neovascular Age-Related Macular Degeneration

    Oct 1, 2017, 00:00

  • Public Hospital Supply Chain- Current View And Critical Issues In Italy

    Oct 1, 2017, 00:00

  • Drug-Safety Program Impact At Health Care Perception At Patients Diagnosed With Persistent Severe Asthma

    Oct 1, 2017, 00:00

  • Transparency Matters- Use Of Digital Software Platform In Replicating Systematic Reviews

    Oct 1, 2017, 00:00

  • Notas Técnicas E Respostas Técnicas Rápidas- Seu Uso Nas Decisões Judiciais Em Saúde

    Oct 1, 2017, 00:00

  • Relación Entre Los Factores Sociodemográfico, Económicos, Condición Clínica Y La Calidad De Vida Relacionada A Salud- Explorando La Eq-5d Y Eq-Vas En Chile

    Oct 1, 2017, 00:00

  • Work Accident Costs. Security, Healthcare and Human Resources Departments Links

    Oct 1, 2017, 00:00

  • Characteristics And Risk Factor Burden Of Patients Receiving Lipid Modifying Therapy In The United Kingdom

    Oct 1, 2017, 00:00

  • Statin Induced Cataract In Cardiovascular Patients- A Retrospective Cohort Study of A Tertiary Healthcare Facility

    Oct 1, 2017, 00:00

  • Impact Of Lifestyle Education And Pharmacist Intervention Of Drug-Related Problems On Elders At High Risk Of Having Dementia

    Oct 1, 2017, 00:00

  • Comparing Cost-Effectiveness of Strategies for Antenatal Hiv Testing- VCT and Routine Testing in Urban Nigeria

    Oct 1, 2017, 00:00

  • Persistence And Concentration Of Prescription Drug Expenditure Among Medicare Beneficiaries 2006-2013

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Obeticholic Acid For The Treatment of Primary Biliary Cholangitis (PBC) Patients With Inadequate Response or Intolerance To Ursodeoxycholic Acid (UDCA) In France

    Oct 1, 2017, 00:00

  • The Application Of Big Data Analysis To Measure And Better Understand Medication Adheren A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Caregiver Burden In Daily Human Growth Hormone Injections For Children

    Oct 1, 2017, 00:00

  • Cost of Type 2 Diabetes Management And Associated Complications In The United Kingdom

    Oct 1, 2017, 00:00

  • What Stroke Image Do We Want? European Clinician Survey On Acute Stroke Imaging And Revascularisation Treatment

    Oct 1, 2017, 00:00

  • Cost-Effectiveness in England of Cabozantinib for Patients with Advanced Renal Cell Carcinoma (ARCC) After Failure of Prior Therapy

    Oct 1, 2017, 00:00

  • Disinvestment of Health Technologies by the National Commission for Technology Incorporation from 2012-2016

    Oct 1, 2017, 00:00

  • Mapping Of Skin And Soft Tissue Infections Worldwide- An Approach From Literature Review

    Oct 1, 2017, 00:00

  • The Impact of Ageing on The Future Costs And Burden of Heart Failure In Portugal

    Oct 1, 2017, 00:00

  • Relaxing Rules For Pharmaceuticals And Benefit Coverage Expansion In Korea- The Impact On The Pharmaceutical Expenditure

    Oct 1, 2017, 00:00

  • HCV Network Of Sicilian Region- A Best Practice To Monitor Cost And Consequence Of Treatments

    Oct 1, 2017, 00:00

  • Burden of Arthritic Manifestations on Psoriatic Patients - Sub-Analysis of Pessoa, A Patient Reported Outcomes Study In Portugal

    Oct 1, 2017, 00:00

  • Characteristics And Approvals Of Regulatory Submissions Based On Non-Randomized Studies In The United States And Europe

    Oct 1, 2017, 00:00

  • Treatment Patterns And Lack of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Attainment Among High-Risk Patients Using High or Moderate Intensity Statin Therapy In Germany

    Oct 1, 2017, 00:00

  • Healthcare Resource Utilization in Patients with Moderate to Severe Crohn’s Disease- A Brazilian Real World Study

    Oct 1, 2017, 00:00

  • Generic Reimbursed Market Shares In Greece From 2012-2016. A Study Based On Age Group Preferences

    Oct 1, 2017, 00:00

  • Hospital Pharmacy Management Of Access To Direct-Acting Antivirals For The Treatment Of Hepatitis C And Its Contribution To Public Health And Economic Efficiency – A Single-Center Experience

    Oct 1, 2017, 00:00

  • Cost-Minimization Analysis of 10% Intravenous Immunoglobulin In Treatment Of Primary Immunodeficiencies In Children In The Russian Federation

    Oct 1, 2017, 00:00

  • Market Access Challenges To PD-1 Immunotherapies- Lessons From Nice

    Oct 1, 2017, 00:00

  • Conditions And Contextual Factors That Influence The Utility And Application Of Patient Preference Studies- A Study Combining Literature And Focus Groups

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Evaluation of Sorafenib As First-Line Treatment for Advanced Hepatocellular Carcinoma

    Oct 1, 2017, 00:00

  • Cost of Nivolumab in Combination with Ipilimumab As First Line Treatment in Advanced Melanoma Across Various European Markets

    Oct 1, 2017, 00:00

  • Health Care Cost In Patients Undergoing Electrical Cardioversion- An Analysis From The Edoxaban Versus Warfarin In Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Study

    Oct 1, 2017, 00:00

  • Using Regression Models To Accommodate Heterogeneity And Address Cohort Imbalance In Parametric Survival Models For Use In HTA

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Second-Line Pharmacological Treatments of Acromegaly In Spain

    Oct 1, 2017, 00:00

  • Comparison of Various Meta-Analysis Techniques

    Oct 1, 2017, 00:00

  • Flaring Among Atopic Dermatitis Patients – The Perception of Flaring Burden Between Physicians and Patients

    Oct 1, 2017, 00:00

  • Pipeline Assessment Of Βeta-Secretase Inhibitors For Alzheimer’s Disease- Hopes Or Gloom For A Trillion Dollar Market

    Oct 1, 2017, 00:00

  • Evaluating the Impact of PCSK9 Inhibitors on Cardiovascular Disease

    Oct 1, 2017, 00:00

  • Intercontinental Links Among Health Technology Assessment Organizations

    Oct 1, 2017, 00:00

  • Examination of Effectiveness of Group Physiotherapy Using Dash Questionnaire After Distal Radial Fracture

    Oct 1, 2017, 00:00

  • Flexible-Dose Depot Buprenorphine Injection for Opioid Substitution Treatment In Heroin-Addicted Adults- A Swedish Pharmacoeconomic Perspective

    Oct 1, 2017, 00:00

  • Substitution Therapy With Flexible-Dose Depot Buprenorphine Injection To Treat Opioid Use Disorder In The United Kingdom- A Pharmacoeconomic Assessment

    Oct 1, 2017, 00:00

  • Adult Risk Factors of Noncommunicable Disease Outcomes

    Oct 1, 2017, 00:00

  • Understanding Hta and Patient Engagement- Effect of Integrating Experiential and Knowledge Learning Modules

    Oct 1, 2017, 00:00

  • Chronic Non-Communicable Diseases (NCDS) and Body Mass Index (BMI) of Beneficiaries and Non-Beneficiaries of Private Health Plans In Brazil

    Oct 1, 2017, 00:00

  • Evaluación Económica De Medicamentos Para El Tratamiento De Síndrome Metabólico Desde La Perspectiva De Un Sistema De Salud Privado En Mexico

    Oct 1, 2017, 00:00

  • Ethical Considerations- Conducting Retrospective Non-Interventional Medical Record Review Studies in Europe

    Oct 1, 2017, 00:00

  • Do Changing Attitudes To Death Have Implications For National Tariffs For Health States? Results From An Examination Of Attitudes To Euthanasia In The Republic Of Ireland

    Oct 1, 2017, 00:00

  • Efficacy and Safety of Topical Dapsone Gel 7.5% for Treatment of Acne Vulgaris by Fitzpatrick Skin Type

    Oct 1, 2017, 00:00

  • Atopic Dermatitis In Adults- Impact on Sexuality

    Oct 1, 2017, 00:00

  • Complementary and Alternative Medicine in the Management of Pain- A South African Community Survey

    Oct 1, 2017, 00:00

  • Profile of Brazilian Inpatients With Mental Disorders Covered By Private Health Care In The State of Ceara- A Real World Data Analysis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of ACEI And ARBS II Drugs In Patients With Arterial Hypertension

    Oct 1, 2017, 00:00

  • Survey Of Life Quality Among Patients With Insulin Dependant Diabetes Mellitus Managed By Insulin Pump

    Oct 1, 2017, 00:00

  • The Unknown Burden Of Celiac Disease In The US And Globally

    Oct 1, 2017, 00:00

  • Medical Cost Evaluation of Apixaban Versus Warfarin In Patients With Nonvalvular Atrial Fibrillation- Japanese Claims Database Analysis

    Oct 1, 2017, 00:00

  • The Effects Of The Economic Crisis On Health Status And Health Inequalities In Greece

    Oct 1, 2017, 00:00

  • Model Structure of Patient-Level Models for Schizophrenia- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Secukinumab Shows Higher Symptomatic improvement Versus Infliximab in Psoriatic Arthritis- Comparative Effectiveness Up To 1 Year Assessed by Matching-Adjusted Indirect Comparisons

    Oct 1, 2017, 00:00

  • School Communities’ Participation In Health Promotion Process In Lithuania

    Oct 1, 2017, 00:00

  • Conitec Reimbursement Decisions- Is There A Cost-Utility Decision Threshold?

    Oct 1, 2017, 00:00

  • Traditional and Complementary Medicine in Pregnancy and Postpartum- Reasons and Perceptions

    Oct 1, 2017, 00:00

  • What Matters to Spanish Patients and Physicians when Facing Decisions for Gep-Net? An Exploration Using a Reflective Multicriteria Shared-Decisionmaking Framework

    Oct 1, 2017, 00:00

  • Costs Analysis Of Novel Flash Glucose Monitoring Technology In Adults With Type 2 Diabetes Mellitus (T2DM) Under Insulin Treatment In Spain

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of A Pharmaceutical Care Program For Systemic Arterial Hypertension Care Into Brazilian Public Heath System

    Oct 1, 2017, 00:00

  • Changes In Treatment Patterns Of Tyrosine Kinase Inhibitors Among Non-Small Cell Lung Cancer Patients Under The National Health Insurance In Taiwan

    Oct 1, 2017, 00:00

  • Waiting List Mortality Impact in Hcv Cirrhotic Patients

    Oct 1, 2017, 00:00

  • Assessment of Lipid-Lowering Therapy Prescribing Among Patients with Type 2 Diabetes Mellitus in Malaysian Primary Care Settings

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of ENTEREX® HPT, A Specialized Nutrition Supplement, for Patients with Liver Disease in Mexico

    Oct 1, 2017, 00:00

  • Comparison of Weighting Methods Used During The Construction of Multiple-Criteria Decision Analysis Tool for Repeated Use In Lower Income Countries

    Oct 1, 2017, 00:00

  • Dosing Patterns Associated With Deflazacort Use In Duchenne Muscular Dystrophy (DMD)- Observations From Deflazacort Early Access Program (EAP) In The U.S

    Oct 1, 2017, 00:00

  • Case Fatality Rate of Enteric Fever- A Systematic Review and Meta-Analysis

    Oct 1, 2017, 00:00

  • Custos Diretos De Eventos Adversos Identificados Em Um Hospital De Grande Porte No Brasil

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Apixaban For Stroke Prevention In Atrial Fibrillation- An Kazakhstan Perspective

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of A Flash Glucose Monitoring System Based On Real-World Usage For Type 2 Diabetes (T2DM) Patients Using Intensive Insulin- A Swedish Perspective

    Oct 1, 2017, 00:00

  • Economic Impact Of Nurse Sensitive Outcomes In Irish Hospitals

    Oct 1, 2017, 00:00

  • Playing in the Same Pond - The Impact of Brexit on Clinical Trials and Access

    Oct 1, 2017, 00:00

  • Cost Effectivness Of Inteligent Liver Function Test(ILFT) For Investigating Patients With Abnormal Liver Function Test

    Oct 1, 2017, 00:00

  • Costs Associated with Disease Progression in Advanced Melanoma - A Claims Analysis Using A Novel Staging Algorithm

    Oct 1, 2017, 00:00

  • Imagem Corporal EM Mulheres Submetidas Ao Tratamento Do Câncer De Mama

    Oct 1, 2017, 00:00

  • Efficient Secondary Use of Representative Social and Health Care Data In Finland- Isaacus Data Lake, Analytics and Knowledge Management Pre-Production Project

    Oct 1, 2017, 00:00

  • A Retrospective Observational Survey of Buprenoprhine/Naloxone Use in France

    Oct 1, 2017, 00:00

  • Payer Management Of High-Cost Brand-On-Brand Combination Therapies In Oncology

    Oct 1, 2017, 00:00

  • Estimating The Economic Benefit Of Treatment With Alpha-Blocker Plus Antimuscarinic As A Fixed-Dose Combination (FDC) Tablet Versus Concomitant Combination Therapy (CCT) In Men With Lower Urinary Tract Symptoms (Luts) Associated With Benign ...

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Extracorporeal Shock Wave Lithotripsy Versus Retrograde Intrarenal Surgery In The Management of Small Moderated-Sized Renal Stones

    Oct 1, 2017, 00:00

  • Prospective Evaluation Of Patient-Centered Care In Short-Term Cancer Survivors, At One And Two Years Post Treatment, Through The Patient Assessment Of Chronic Illness Care Questionnaire

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life (HRQOL) and Disease Symptoms in Patients with Unresectable Hepatocellular Carcinoma (HCC) Treated with Lenvatinib (LEN) or Sorafenib (SOR)

    Oct 1, 2017, 00:00

  • Evaluation Of Branding Impact On Iranian Pharmaceutical Market- A Qualitative Study

    Oct 1, 2017, 00:00

  • Drug Cost Containment And Negotiation Power

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Medication Review Interventions- A Review Of Literatures

    Oct 1, 2017, 00:00

  • Risk Factors And Diagnosis Of Nontuberculous Mycobacterial Lung Disease (NTMLD) In Incident Cohorts Of Bronchiectasis (BE) And Chronic Obstructive Pulmonary Disease (COPD) In A National US Managed Care Insurance Plan

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Plurogel® - A New Micelle-Matrix-Based Dressing With 1% Silver Sulphadiazine – In The Management of Non-Healing Wounds

    Oct 1, 2017, 00:00

  • Revisiting Indirect Health Preference Elicitation As A Base Case

    Oct 1, 2017, 00:00

  • Practical considerations for a dialysis provision model of care for end-stage renal disease (esrd). Benchmark of international experiences, opportunities for the mexican social security institute (imss)

    Oct 1, 2017, 00:00

  • Preferences for Route of Administration, Frequency and Location - A Time-Trade-Off Study in the Italian General Population

    Oct 1, 2017, 00:00

  • Early HTA Advice In European Countries- Scope And Associated Costs

    Oct 1, 2017, 00:00

  • Clinical Efficacy And Safety Of Licensed Drugs And Potential New Therapies For Non-Metastatic Castration-Resistant Prostate Cancer- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Using Real-World Data (RWD) in Health Technology Assessment (HTA) Practi A Comparative Study of 5 HTA Agencies

    Oct 1, 2017, 00:00

  • Rheumatoid Arthritis Patients’ Perspectives On The Value Of Patient Preferences In Regulatory Decision-Making During Drug Development- A Qualitative Study

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Daclatasvir/Sofosbuvir (DCV/SOF) For The Treatment Of HCV Patients Who Failed After First Line Treatment With Second Generation Of Daa In Italy

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Inpatient Rehabilitation Compared To Home Discharge Following Longer Stay In General Or Neurological Ward, After Admission For The First Ever Stroke In Greece

    Oct 1, 2017, 00:00

  • Análise De Custo-Comparação Entre Os Programas Para Pessoas Com Deficiência Intelectual E Do Desenvolvimento Cognitivo- Suporte Individualizado E Instituições De Saúde Mental

    Oct 1, 2017, 00:00

  • Economic Impact Of Severe Asthma In Spain- Observational Longitudinal Multicenter Study

    Oct 1, 2017, 00:00

  • Bringing Molecular Diagnostic Tests Into Clinical Practi Mapping The Evidence Pathway

    Oct 1, 2017, 00:00

  • Confirmatory Versus Explorative Endpoint Analysis- Decision-Making Under Uncertainty on The Basis of Evidence Available From Market Authorization And Early Benefit Assessment In Germany

    Oct 1, 2017, 00:00

  • Analysis Of Financial Status And The Investment Strategy Of National Hospital Organization (NHO) In Japan From 2004 TO 2015

    Oct 1, 2017, 00:00

  • Classification of Causes of Hospitalization For Heart Failure Patients In Cost-Effectiveness and Cost-Utility Evaluations of Pharmacotherapeutic, Surgical, and Managed-Care Interventions- Systematic Review

    Oct 1, 2017, 00:00

  • An Assessment Of Correlation Between Mortality And Distance From Patient’s Residence To Interventional Center In Percutaneous Coronary Intervention In Brazil

    Oct 1, 2017, 00:00

  • Very Low Compliance for Vulvovaginal Atrophy (VVA) Treatment- A Retrospective U.S. Healthcare Claims Database Analysis

    Oct 1, 2017, 00:00

  • Health State Utilities In Patients with Relapsing Remitting Multiple Sclerosis Treated with Cladribine Tablets

    Oct 1, 2017, 00:00

  • A Multicenter, Observational Study To Evaluate Comorbidities In Patients Above 50 Years of Age – Aging Positive- A Comparison of Medical Charts And Patients Self-Reported Data

    Oct 1, 2017, 00:00

  • European Initiatives To Enhance Biosimilar Adoption

    Oct 1, 2017, 00:00

  • Evaluación De La Costo-Efectividad De La Prueba De Secuenciación Completa Del Gen Cftr Por Técnica Sanger Para Portadores Asintomáticos En Población Colombiana De Primer, Segundo Y Tercer Grado De Consanguinidad Con Historia Familiar De Fib ...

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Assessment of Sucroferric Oxyhydroxide Vs Sevelamer Carbonate In Patients With Chronic Kidney Disease In Belgium and The Netherlands

    Oct 1, 2017, 00:00

  • Survey Of Nurses’ Knowledge About Surgical Wound Care And Its Complications And The Knowledge Of Wound Dressings

    Oct 1, 2017, 00:00

  • The Impact of The Learning Curve on Costs and Effects of Novel Medical Devices. Evidence From Registry Data

    Oct 1, 2017, 00:00

  • Cost Per Median Overall Survival Associated with Abiraterone Acetate and Enzalutamide For Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer in Colombia

    Oct 1, 2017, 00:00

  • Burden of Healthcare Costs for Merkel Cell Carcinoma Management in Spain

    Oct 1, 2017, 00:00

  • Spanish Patient’s Perspective and Preferences for Telemedicine Resources in Type 2 Diabetes Management

    Oct 1, 2017, 00:00

  • Assessing Preferences in Discrete Choice Experiments (DCES)- Effects of the Applied Design on the Study Results

    Oct 1, 2017, 00:00

  • Disease Burden During The “Watchful Waiting” Period In Women With Recurrent Ovarian Cancer In Germany

    Oct 1, 2017, 00:00

  • Access Gap To Innovative Treatments In Romania

    Oct 1, 2017, 00:00

  • No Price Negotiation – The Strategy Of Aok Bavaria Tested – For Inpatient Hemophilia Care

    Oct 1, 2017, 00:00

  • Development of Pharmacoeconomic Guidelines In Ukraine- Methodological Issues And Policy Implications

    Oct 1, 2017, 00:00

  • Budget Impact Of Newly Approved Drugs By The Sicilian Drug Formulary Committee- An Introductive Analysis

    Oct 1, 2017, 00:00

  • A Network Meta-Analysis to Compare the Efficacy and Safety Of Antipsychotics As Maintenance Treatment For Patients With Schizophrenia

    Oct 1, 2017, 00:00

  • Comparison Ofsecukinumab Vs Adalimumab in a Cost Per Responder Analysis Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatment of Psoriatic Arthrisis at 48 Weeks from a Moroccan Perspective

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis Of Darunavir-Based Regimens For Treatment-Experienced Patients With Multidrug-Resistant HIV-1 Infection In Thailand

    Oct 1, 2017, 00:00

  • Evaluation Framework for Digital Medicines in Europe

    Oct 1, 2017, 00:00

  • Characterization of Low Density Lipoprotein (LDL) Levels in Patients Diagnosed with Arterial Hypertension and Diabetes in Colombian Population in the Year 2016

    Oct 1, 2017, 00:00

  • Perceived Service Quality And Patient Satisfaction At Pharmacy Department In Yogyakarta, Indonesia

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Vaccines- What Are The Methodological Issues?

    Oct 1, 2017, 00:00

  • Comparison of Methods to Measure Patient Adherence and Persistence with Pharmacological Therapy- A Systematic Review

    Oct 1, 2017, 00:00

  • A Network Meta-Analysis to Evaluate The Efficacy of Brodalumab in the Treatment of Moderate-To-Severe Psoriasis

    Oct 1, 2017, 00:00

  • Non-Interventional Real-World European Study Quantifying The Burden Of Central Nervous System (CNS) Metastases On Healthcare Resource Use (HRU) In Patients With Metastatic Non-Small-Cell Lung Cancer (MNSCLC) – Results From An Interim Analys ...

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Mechanical Thrombectomy Compared with Standard Treatment in Patients with Acute Ischaemic Stroke

    Oct 1, 2017, 00:00

  • Assessing The Robustness Of Direct Meta-Analysis In The Presence Of Heterogeneity

    Oct 1, 2017, 00:00

  • Valor Monetario De Las Muertes De Motociclistas En Colombia

    Oct 1, 2017, 00:00

  • Knowledge And Attitudes Identifying Victims Of Human Trafficking In The US- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Assessment of The Efficacy of The Two-Year Treatment With Omalizumab, According to The Pediatric Registry of The Children with Severe Persistent Uncontrolled Asthma

    Oct 1, 2017, 00:00

  • The Impact of Disability on Activities of Daily Living, Productivity and Independency in Patients with Multiple Sclerosis- Findings from a 2016 Study in Europe and the United States

    Oct 1, 2017, 00:00

  • Patient-Reported Outcomes of Opioid-Induced Constipation as Identified Through Social Media

    Oct 1, 2017, 00:00

  • Cost of Non-Union In Patients with Lower Leg Fractures

    Oct 1, 2017, 00:00

  • Clinical Outcomes of Theophylline use as Add-On Therapy In Patients with Chronic Obstructive Pulmonary Disease- A Propensity Score Matching Analysis

    Oct 1, 2017, 00:00

  • Matching Adjusted Indirect Comparison Of Sunitinib And Everolimus For The Treatment Of Pancreatic Neuroendocrine Tumours (PNETS)

    Oct 1, 2017, 00:00

  • Trend In Hospital Cases of Acquired Hemophilia A (AHA) 2010-2015 In Germany

    Oct 1, 2017, 00:00

  • Using Diabetes Self-Management Questionnaire (DSMQ) to Assess Diabetes Self-Care Activities for Diabetes Patients in King Fahad University Hospital - Saudi Arabia

    Oct 1, 2017, 00:00

  • Attitude Of Pakistani Pharmacy Students Towards Postgraduate Education

    Oct 1, 2017, 00:00

  • Acne Vulgaris- Prevalence, Clinical forms and its Management in Pharmacy Students from Bahawalpur, Pakistan

    Oct 1, 2017, 00:00

  • Analgesics Prescription Pattern In A Specialist Teaching Hospital In Southeast Nigeria

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Interventions That Have Not Shown Clinical Effectiveness

    Oct 1, 2017, 00:00

  • Estimating The Lifetime Total Economic Costs Of Respiratory Disease In Beef And Dairy Calves In The UK

    Oct 1, 2017, 00:00

  • The Relationship Between Severity of Chronic Kidney Disease and Health Related Quality of Life Among a Nationally Representative Sample of Community Dwelling Adults in England

    Oct 1, 2017, 00:00

  • Epidemiology Of Healthcare Registered As Sexual Abuse Against Women In Brazil

    Oct 1, 2017, 00:00

  • Prescribing Pattern Of Antibiotics For Acinetobacter Infection In A Tertiary Care Hospital

    Oct 1, 2017, 00:00

  • Adjusting for Selection Bias in Evaluating Two-Dose Human Papillomavirus Vaccine Coverage Among Adolescents in the United States

    Oct 1, 2017, 00:00

  • Health State Utilities in Individuals with Goiter, Hypothyroidism, Hyperthyroidism and Graves’ Disease as an Example for Thyroid Disorders – A Systematic Review

    Oct 1, 2017, 00:00

  • Economic Analysis of Alk Related Companion Diagnosis Methods Before the Targeted Therapy for Non-Small Cell Lung Cancer

    Oct 1, 2017, 00:00

  • Boceprevir and Telaprevir Effectiveness and Safety in A Brazilian Cohort of Chronic Hepatitis C Genotype 1 Patients- A Multicentric Longitudinal Study

    Oct 1, 2017, 00:00

  • Gamification, What Is It and How Can It Be Used In Health Outcomes Research?

    Oct 1, 2017, 00:00

  • Cost Comparison of Treatment Choices for Advanced Non-Small Cell Lung Cancer- An Observational Study

    Oct 1, 2017, 00:00

  • Plan De Atencion De Cuidados Paliativos Y Cuidados De Fin De Vida

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns in Metastatic and/or Unresectable Gastric Cancer in Patients From Argentina

    Oct 1, 2017, 00:00

  • German Situation of Treatment with Biological Agents Among Patients with Psoriasis Based on A Claims Data Analysis

    Oct 1, 2017, 00:00

  • Comparison Of Standard Parametric Survival Methods Versus More Flexible Approaches

    Oct 1, 2017, 00:00

  • Does Using Factor Analysis to Select Covariates in Mapping Algorithms Improve Predictive Accuracy? A Case of Mapping the Core 23-Item Women’s Health Questionnaire Onto the EQ-5D-5L and SF-6D

    Oct 1, 2017, 00:00

  • Does Community-Based Health Insurance Reduce Child Stunting? Evidence From Rural Uganda

    Oct 1, 2017, 00:00

  • Predictive Analysis for Identifying Patient Characteristics Associated with Primary Medication Nonadherence for Lipid Lowering Therapies

    Oct 1, 2017, 00:00

  • Guideline Adherence In Docetaxel Treatment Of Castration Resistant Prostate Cancer (CRPC) Patients In A Real-World Population- The Castration Resistant Prostate Cancer Registry (CAPRI) In The Netherlands

    Oct 1, 2017, 00:00

  • The Case For Combination Therapy - Clinical And Economic Value Differentiation Strategies In Saturated Oncology Therapy Areas

    Oct 1, 2017, 00:00

  • Aedes Aegypt- Economic Impact of Prevention Versus Palliation of Diseases Caused By The Mosquito

    Oct 1, 2017, 00:00

  • Budget Impact of Alectinib in The Treatment of Naïve Anaplastic Lymphoma Kinase-Positive (ALK+) Advanced Non-Small Cell Lung Cancer (NSCLC) in Greece

    Oct 1, 2017, 00:00

  • Real World Data In France – State of The Art

    Oct 1, 2017, 00:00

  • Using Ticagrelor to Enhance Outcomes for Acute Coronary Syndromes (ACS) Patients at Low Middle Income Countries

    Oct 1, 2017, 00:00

  • Resource use and Health-Care Costs of Chronic Lymphocytic Leukemia in Slovakia

    Oct 1, 2017, 00:00

  • Which PSM Method To Use? Association Between Chosen Ppropensity Score Method And Outcomes Of Retrospective Real-World Treatment Comparisions- Evaluation Of 18 Different PSM Methods

    Oct 1, 2017, 00:00

  • Price-Dose Relationship- The Case of Oral Oncology Drugs in Eu5

    Oct 1, 2017, 00:00

  • Assessing The Burden Of Chronic Heart Failure (Chf) On Patients’ Caregivers In Argentina

    Oct 1, 2017, 00:00

  • Pharmaceutical Assistance Public Funding In A Brazilian City And Its Implications For The Universal Access To Essential Medicines

    Oct 1, 2017, 00:00

  • A Systematic Review Of Predictive Models In Acute Heart Failure

    Oct 1, 2017, 00:00

  • Secukinumab Significantly Reduces Work Impairment and Indirect Costs Compared To Ustekinumab and Etanercept In The United Kingdom

    Oct 1, 2017, 00:00

  • Prioritizing Patient-Relevant Attributes of HIV Medications- A Mixed Methods Approach

    Oct 1, 2017, 00:00

  • Value Added Medicines- Adjustements of HTA Decision Frameworks To Capture Their Full Value

    Oct 1, 2017, 00:00

  • Comparative Efficacy and Safety of Interventions For Preventing Chemotherapy Induced Oral Mucositis In Adult Cancer Patients- A Systematic Review And Network Meta-Analysis

    Oct 1, 2017, 00:00

  • Occurrence or Remission of Antidiabetic Treatment Six Years after Bariatric Surgery- A Nationwide Matched Cohort Study

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Adopting Evolocumab In The Brazilian Private Healthcare System For Patients With Uncontrolled LDL-C And High Cardiovascular Risk

    Oct 1, 2017, 00:00

  • Severe Depression as a Risk Factor for Osteoporosis- A Real World Data Study Conducted in Italy

    Oct 1, 2017, 00:00

  • Decreasing Acef Score In Patients Underwent Myocardial Infarction Affects Patients’ Life Years Gained

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Treprostinil To Treatment of Patients With Pulmonary Arterial Hypertension Nyha Class Iv Without Response To Pharmacological Therapies In Mexico

    Oct 1, 2017, 00:00

  • Ethical Requirements for the Conduct of Drug Utilization Studies in Latin America- A Cross-Sectional Survey

    Oct 1, 2017, 00:00

  • Costs of Chemotherapy-Induced Adverse Events in Head and Neck Cancer in France

    Oct 1, 2017, 00:00

  • Appropriate Ankylosing Spondylitis (AS) Treatment is Delayed For Years- Results From a Multi-National Survey Including Latin America

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Crizotinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung Cancer in Portugal

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Brentuximab Vedotin As Consolidation Treatment After Autologous Stem-Cell Transplantation in Patients With Hodgkin Lymphoma and Increased Risk of Relapse

    Oct 1, 2017, 00:00

  • Comparative Analysis of The Development of The Bulgarian and The Romanian HTA System

    Oct 1, 2017, 00:00

  • Efficacy and Cost-Effectiveness of Second-Line Chemotherapy in Elderly Patients with Advanced Gastric Cancer

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Pirfenidone Versus Nintedanib on The Treatment of Idiopathic Pulmonary Fibrosis

    Oct 1, 2017, 00:00

  • Herpes Zoster Related Healthcare Burden And Costs In Both Immunocompromised (IC) And Ic-Free Populations In The United Kingdom

    Oct 1, 2017, 00:00

  • Worldwide Research Productivity on Biosimilars- A Bibliometric Analysis

    Oct 1, 2017, 00:00

  • Cost Utility Analysis of Single Fraction Versus Multiple Fraction Radiotherapy in Patients with Painful Bone Metastases; an Iranian Patient's Perspective Study

    Oct 1, 2017, 00:00

  • Estimating the Financial Impact of Introducing Glycopyrronium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) From the Perspective of Public Payer of São Paulo (Sp) – Brazil

    Oct 1, 2017, 00:00

  • Costo Utilidad De Los Bloqueadores HER2 Contra El Cáncer De Mama Metastásico En Mujeres Peruanas

    Oct 1, 2017, 00:00

  • Costo-Efectividad De La Deteccion De Adn De Virus De Papiloma Humano De Alto Riesgo Para Tamizaje De Cancer De Cuello Uterino En Ecuador

    Oct 1, 2017, 00:00

  • Patient-Reported Outcomes from Phase 3 Baricitinib Ra-Beam Study- Latin American Subgroup Analysis

    Oct 1, 2017, 00:00

  • Clinical Trial Simulations Based on A Meta-Analysis of Studies In Patients With Locally Advanced and/or Metastatic Adenocarcinoma Pancreatic Cancer Receiving Gemcitabine (GEM) Alone or In Combination

    Oct 1, 2017, 00:00

  • An Economic Evaluation Model for Follicular Lymphoma (FL)- Predicting Treatment Cost, Life Expectancy and Quality-Adjusted Life Year of Different Scenarios Using UK Population Based Observational Data

    Oct 1, 2017, 00:00

  • Clinical And Economic Value Of Device-Based Detection Of Atrial Fibrillation In Patients With Cryptogenic Stroke

    Oct 1, 2017, 00:00

  • Impact Of Health Policies On Catastrophic Health Expenditures In Turkey

    Oct 1, 2017, 00:00

  • Prevalence of and Barriers to Medication Adherence Among Patients with Uncontrolled Diabetes Mellitus in Primary Healthcare Centers in Qatar- A Quantitative Analysis

    Oct 1, 2017, 00:00

  • What is The Economic Impact of CCP Test Misclassification in Rheumatoid Arthritis Diagnosis? A Benchmarking Simulation Study in Spain

    Oct 1, 2017, 00:00

  • Análisis De Impacto Presupuestario Comparando 2 Métodos De Screening De Cáncer De Cuello Uterino (CCU) EN EL Sector De Obras Sociales De Argentina

    Oct 1, 2017, 00:00

  • Burden of Genital Warts in Argentina. Preliminary Report of an Observational Study

    Oct 1, 2017, 00:00

  • GDP And Population Size – Important Determinants of Schizophrenia-Related Healthcare Costs In The European Countries

    Oct 1, 2017, 00:00

  • Economic Evaluation of Egfr Control In Patients With Chronic Kidney Disease In Japan

    Oct 1, 2017, 00:00

  • Economic Evaluation of Trifluridine and Tipiracil Hydrochloride in The Treatment of Metastatic Colorectal Cancer in Greece

    Oct 1, 2017, 00:00

  • Health Effects of Micronutrient Fortified Milk and Cereal Food for Children and Adolescents- A Systematic Review

    Oct 1, 2017, 00:00

  • Health Related Quality of Life in Cancer Immunotherapy- Previously Treated, Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

    Oct 1, 2017, 00:00

  • A Review Of Methodology And Response To Iqwig Report “Treatment Of Haemophilia Patients”

    Oct 1, 2017, 00:00

  • Real-World Health Care Resource Utilization and Related Costs Among Patients Who Received At Least Two Lines of Treatment for Advanced Nsclc in England, The Netherlands, and Sweden

    Oct 1, 2017, 00:00

  • Ixekizumab Treatment Improves Itching And Health-Related Quality (HRQOL) of Life In Psoriasis Patients In Latin America

    Oct 1, 2017, 00:00

  • A Discrete Choice Experiment To Elicit Diabetes Treatment Preferences Among Adolescents With Type 1 In Western Australia

    Oct 1, 2017, 00:00

  • Characteristics Of Patients Treated With Cetuximab-Based Extreme Regimen In 1ST Line R/M Scchn Cancer In Real Life Setting, In France In 2012-2015

    Oct 1, 2017, 00:00

  • Impacto Económico De La Hipoglucemia En Colombia

    Oct 1, 2017, 00:00

  • Pathways to Dementia Diagnosis and Post-Diagnostic Support- the Bavarian Dementia Survey

    Oct 1, 2017, 00:00

  • Accurate Representation Of Patients’ Opinions For Decision-Making- Are Online Health Communities Good Candidates?

    Oct 1, 2017, 00:00

  • Mapping from SF-36 Trial Data To EQ-5D Utilities in Advanced Basal Cell Carcinoma

    Oct 1, 2017, 00:00

  • Patients’ Preferences Related to Treatments for Endometriosis-Related Pain- Results of a Discrete Choice Experiment in the UK

    Oct 1, 2017, 00:00

  • A Qualitative Exploration of Reasons for (NON-) Adherence to Oral Anticoagulant Therapy in Patients with Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Early Modelling of The Cost-Effectiveness of Stratified Medicine In COPD

    Oct 1, 2017, 00:00

  • Comparison Of Women’s Health Care In Germany, Austria And Switzerland Regarding Surgical Therapy Options For Patients With Abnormal Uterine Bleeding

    Oct 1, 2017, 00:00

  • Non-Opioid Analgesic Reimbursement In Europe- A Comparative Study

    Oct 1, 2017, 00:00

  • Evaluation Of Structured Educational Intervention To Community Pharmacists Towards Adverse Drug Reaction Reporting And Monitoring In South Indian District

    Oct 1, 2017, 00:00

  • Moving Pro Measures from the Promise to Impact in Oncology Clinical Practi Results from a Systematic Literature Review

    Oct 1, 2017, 00:00

  • Treatment Patterns of Chronic Heart Failure (CHF) In Mexico

    Oct 1, 2017, 00:00

  • Real World Data Analysis Of A Patient-Tailored, Post-Discharge Support Program For Patients Undergoing An Ostomy Surgery In Lowering Readmissions And Emergency Room Visits

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of A Randomized Trial Of An Mhealth Intervention To Improve Cardiometabolic Profile In Prehypertensive Subjects From Low-Resource Urban Settings In Latin America

    Oct 1, 2017, 00:00

  • Inappropriate Prescribing of Antithrombotics Causes Poor Discharge Outcomes In Hospitalized Elderly Patients Using Stopp/Start Criteria 2015, A Retrospective Cohort Study

    Oct 1, 2017, 00:00

  • Crises Econômicas E Seus Impactos No Sistema De Saúde Do Brasil

    Oct 1, 2017, 00:00

  • Estimating The Prevalece of Depression In Patients With Rheumatoid Arthritis In Korea Using National Health Insurance Claims Data

    Oct 1, 2017, 00:00

  • Benefit-Risk And Medical Costs of Rivaroxaban 15mg Versus Vitamin K Antagonists From A French Nationwide Cohort of 220,000 Patients With Non-Valvular Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Prediction Of Costs On Antiretroviral Therapy In The Republic Of Belarus

    Oct 1, 2017, 00:00

  • Patterns of Biologics Use In Ankylosing Spondylitis And Psoriatic Arthritis Patients In Korea

    Oct 1, 2017, 00:00

  • Management And Cost Analysis Of Cancer Patients Treated With G-CSF- A Cohort Study Based On The French National Healthcare Insurance Database (Echantillon Généraliste Des Bénéficiaires)

    Oct 1, 2017, 00:00

  • Health Technology Assessment To Improve Patient Care Through Pharmaceutical Care- Clinical Pharmacist’s Perspective

    Oct 1, 2017, 00:00

  • PCN3 Pattern of Chemotherapy Related Adverse Effects Among Adult Cancer Patients Treated At Gondar University Referral Hospital, Ethiopia- A Cross Sectional Study

    Oct 1, 2017, 00:00

  • Characterizing The Utilization of The Trillium Drug Program by An Oncology Patient Population

    Oct 1, 2017, 00:00

  • 3-Steps Stragety for Patients Early Access to an Unauthorized Medication / Device Project Design (Based on 23 Projects Analyses Including EAP, CUP, NPP, IND, ATU)

    Oct 1, 2017, 00:00

  • Structural Change In The Hungarian Health Care System

    Oct 1, 2017, 00:00

  • Effect of Gastrointestinal Adverse Events on Treatment Satisfaction in Semaglutide Treatment of Type 2 Diabetes

    Oct 1, 2017, 00:00

  • ECONOMIC Evaluation of Nt-Probnp Guided Therapy in Patients with Chronic Heart Failure

    Oct 1, 2017, 00:00

  • Managed Entry Agreements (MEA)- Analysis Of The Current Situation In Middle East And North Africa

    Oct 1, 2017, 00:00

  • Evaluation of Pharmacist’s Educational and Counseling Impact on Patients Clinical Outcomes in a Diabetic Setting

    Oct 1, 2017, 00:00

  • Spontaneous Abortion is Associated with an Increased Risk of Developing Psychiatric Diseases

    Oct 1, 2017, 00:00

  • The Comparative Pharmacoeconomic Analysis of Using Different Agonists of The Thrombopoietin Receptor In Adult Patients With Chronic Idiopathic Thrombocytopenic Purpura In Actual Practice In Russia

    Oct 1, 2017, 00:00

  • Calidad De Vida En Salud En Pacientes Amputados De Extremidad Inferior Con Protesis De Un Hospital De Especilidad Público Chileno

    Oct 1, 2017, 00:00

  • COMPARISON OF VARIOUS SEVERITY ASSESSMENT SCORING SYSTEMS IN PATIENTS WITH SEPSIS

    Oct 1, 2017, 00:00

  • Patient Perception With Respect To The Overall Experience To A Patient-Friendly Equipment Design And The Impact Of Patient-Assisted Compression Feature During A Mammography Exam

    Oct 1, 2017, 00:00

  • Costs Of Ownership Of Ready-To-Administer Pre-Filled Sterilized Syringes In A Dutch Hospital; A Cost Minimization Analysis

    Oct 1, 2017, 00:00

  • The Impact of The Rads Assessment- Can Fewer Injections With Intravitreal Aflibercept Translate To Lower Overall Treatment Burden and Costs In Wamd When Compared With Intravitreal Ranibizumab?

    Oct 1, 2017, 00:00

  • Opportunity Cost Of Non-Rigorous Or Non-Transferable Research- Implications For Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Custo Efetividade Do Uso Dos Inibidores De Protease No Tratamento Da Hepatite C Crônica- Comparação Entre O Uso Universal E O Uso Restrito Na Fibrose Avançada

    Oct 1, 2017, 00:00

  • Patient Input into Value Assessment of Respiratory Medicines- Lessons Learned from Value Frameworks in other Disease Areas

    Oct 1, 2017, 00:00

  • Influence of Computer Games on the Health and Quality of Students Academic Performance

    Oct 1, 2017, 00:00

  • PRM178Evaluation And Validation Of The Proact Measures For Cancer Patients And Informal Caregivers

    Oct 1, 2017, 00:00

  • Comparing ITC Results From Lenvatinib Plus Everolimus For Second-Line Treatment of Advanced/Metastatic Renal Cell Carcinoma- Crossover Versus No Crossover

    Oct 1, 2017, 00:00

  • Characteristics And Treatment Patterns In Patients Treated For Relapsed Refractory Multiple Myeloma Over 3 Years- Premiere Study

    Oct 1, 2017, 00:00

  • Value Based Healthcare In Orthopaedic Surgery- An Evaluation Based On The Economist Intelligence Unit Global Assessment Framework

    Oct 1, 2017, 00:00

  • Predicting Outcomes From Multiple Uncontrolled Historical Studies of Treatment of Physician’s Choi Progression-Free Survival And Overall Survival In Untreated Metastatic Merkel Cell Carcinoma

    Oct 1, 2017, 00:00

  • Quality Of Reporting And Analysis Of Trial-Based Cost Efectiveness Evaluations In Obstetrics And Gynaecology; A Systematic Review

    Oct 1, 2017, 00:00

  • Sentiment Analysis of Social Media Posts from Renal Cell Carcinoma (RCC) Patients

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Aspects of Various Strategies of Vessel Sealing and Reduction of Postoperative Complications of Inguinal Lymph Nodes Dissection in Patients with Gynecologic Cancers

    Oct 1, 2017, 00:00

  • Economic Evaluation of Strategies For Public Cervical Cancer Screening

    Oct 1, 2017, 00:00

  • Idiopathic Pulmonary Fibrosis- Where The Functional Health Deterioration and The High Economic Impact Are Inseparable. Challenges In A Latin American Country

    Oct 1, 2017, 00:00

  • A Cost-Utility Analysis Comparing Two Sequences of Treatment for First-Line Chemotherapy in Metastatic Prostate Cancer (MCRPC)- Cabazitaxel Followed by Docetaxel Versus Docetaxel Followed by Cabazitaxel

    Oct 1, 2017, 00:00

  • Improper Medication Use By The Aged Population In Bahria Town, Lahore, Punjab, Pakistan

    Oct 1, 2017, 00:00

  • Depression Assessment in Patients Diagnosed with Parkinson’s Disease for Clinical Practice

    Oct 1, 2017, 00:00

  • Economic Evaluation of Dialysis Dependence Following Renal Replacement Therapy for Critically ILL Acute Kidney Injury Patients

    Oct 1, 2017, 00:00

  • The Use Of Matching Adjusted Indirect Comparison (MAIC) And Simulated Treatment Comparison (STC) In Hta Submissions; Learnings From Recent Submissions

    Oct 1, 2017, 00:00

  • Labour Productivity Losses Associated with Breast Cancer- An Analysis Along A Decade in Spain

    Oct 1, 2017, 00:00

  • Local Production Policies In The Turkish Pharmaceutical Market

    Oct 1, 2017, 00:00

  • Evolución De La Calidad De Atención En Personas Con Diabetes Tipo 2 (DMT2) De Argentina- Resultados Del International Diabetes Management Practices Study (IDMPS)

    Oct 1, 2017, 00:00

  • Inter-State Variability Of Adult Vaccination Coverage In The United States- Can We Explain It?

    Oct 1, 2017, 00:00

  • The Practice of Decision-Making of Public Health Authorities In Poland on Reimbursement of Orphan Drugs

    Oct 1, 2017, 00:00

  • Damned if You ‘D’? Evidence the Selection of the Appraisal Committee May Affect Nice Technology Assessmet Outcomes

    Oct 1, 2017, 00:00

  • The Incidence Of Liver Complications In Israel

    Oct 1, 2017, 00:00

  • Assessing The Joint Probability Of Cost-Effectiveness And Affordability In Decision Making

    Oct 1, 2017, 00:00

  • Does The Reimbursement Of In-Patient Hospital Services Adequately Cover Novel Antibiotic Pharmaceuticals In The U.S., EU4 And England? Discussion Of Current Mechanisms In Place

    Oct 1, 2017, 00:00

  • Hydrogen Peroxide As A Sustainable Alternative for Sterilization

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis of Dimethyl Fumarate Versus Teriflunomide for The Treatment of Multiple Sclerosis

    Oct 1, 2017, 00:00

  • Preferences for Survival in Non-Small Cell Lung Cancer- Swinging for Home Runs or Base Hits?

    Oct 1, 2017, 00:00

  • Assessment of Healthcare Costs of Infants In Exclusive Breastfeeding Versus Mixed or Artificial Breastfeed

    Oct 1, 2017, 00:00

  • An Algorithm To Quantttatively Estimate Extrapolated Lifetime Survival Curves For Economic Evaluation (EE) of Cancer Treatments When Only Aggregated Patient Data Are Available; With Application To Metastatic Pancreatic Cancer

    Oct 1, 2017, 00:00

  • Changes In Private Financing Of The Greek Health System During The Economic Crisis

    Oct 1, 2017, 00:00

  • Evidence Syntheses On The Economic Value Of Hospital Antimicrobial Stewardship Programs [ASPS] – A Call To Action

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Chidamide Versus Chemotherapy on The Treatment of Peripheral T - Cell Lymphoma Patients In China

    Oct 1, 2017, 00:00

  • A Study on Evaluation of Fall Risk Among Geriatric Patients At A Tertiary Care Public Teaching Hospital

    Oct 1, 2017, 00:00

  • Characterisitcs of Patients Receiving Leflunomide, Methotrexate or Leflunomide Plus Methotrexate for the Treatment of Rheumatoid Arthritis in a Real-Life Setting in Colombia

    Oct 1, 2017, 00:00

  • Systematic Literature Review And Indirect Treatment Comparison of The Efficacy of Semaglutide Versus Empagliflozin As Add-on To Basal Insulin

    Oct 1, 2017, 00:00

  • Patterns of Biological Therapy Use in Patients with Rheumatoid Artrhitis in a Real-Life Setting in Colombia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Atezolizumab Compared To The Standard of Care For The Treatment of Adult Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy in Greece

    Oct 1, 2017, 00:00
  • «
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79 (current)
  • 80
  • »